Work

S41 The Real-Time Nondrug Cost Savings of Switching Patients With Inflammatory Bowel Disease From Intravenous to Subcutaneous Vedolizumab: A Time and Motion Study

Year: 2024

Type: conference-abstract

Source: The American Journal of Gastroenterology

DOI: 10.14309/01.ajg.0001082696.25666.d9

Authors: Yaser Meeralam, Adnan Alzanbagi, Mohammed Khan, Mona Alsaedi, Salem Alotaibi, Saad Alzahrani, Zaffar Malik, Mohammed Sulaimani, Abdullah Samanudi, Mohammed K. Shariff

Institution: King Abdullah Medical City

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405168517

Cites:

Cited by:

Related to: 10